We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech, and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions.
We connect best-in-class scientific knowledge and cutting-edge tech to create compelling content and experiences that inform, inspire and involve medical communities across the healthcare spectrum.
By intelligently connecting the right insights, technology, and expertise, we help our customers and partners do extraordinary things for healthcare.
Komodo Health is a healthcare technology company creating the new standard for real-world data and analytics through its platform, which enables real-time, actionable insight into the treatment, diagnosis, costs, and outcomes of millions of patients across the U.S.
We provide best-in-class specialized services, with the ability to partner with a large network of teams across Inizio Medical.
Neolytica, a QPharma Company is the premier leader in cloud-based commercial and compliance SaaS solutions and has been providing services to our clients for the last 25 years and its flagship technology platform Titanium® is utilized by 120+ Clients in 2022. Our vision is to help Biopharma companies gain an unprecedented level of support in their KOL engagement leading to overall successful product placement.
Driving innovation in the many facets of medical communication, marketing, and education, we believe creative solutions arise when insatiable curiosity combines with a passion for making positive impacts.
Medscape Medical Affairs partners with medical affairs teams through a product’s life cycle. We facilitate optimal collaboration between internal teams, physicians, and the broader medical community, connecting you directly with our five million physician members worldwide.
With specialization in chronic conditions, OM1 is re-imagining real-world data and evidence.
Precision AQ partners with life science companies to establish and communicate the clinical, economic, and humanistic value of innovative therapies.